Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world. Climate change and ESG.

Government 52

Government Healthcare Healthcare Pharma 52

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. Healthcare executives are also looking into AR spinal surgical systems.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Medico Reach

FEBRUARY 8, 2023

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. from 2023 to 2030. Poised to grow at a CAGR of 29.4% billion in 2022 and will expand at a CAGR of 10.3%

Pharma 52

Pharma Medicine Marketing Prospecting 52

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. Healthcare executives are also looking into AR spinal surgical systems.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

Healthcare Success

NOVEMBER 14, 2022

billion in 2030 ). The Patient Protection and Affordable Care Act of 2010 has increased access to healthcare services for previously uninsured populations. When selling healthcare technology products and medical devices, you must comprehensively understand your target market. billion in 2022 to 964.90 Know Your Buyer Persona.

Medical 65

Medical Marketing Engineering Doctors 65

Clarivate

MAY 31, 2023

According to figures from the Healthcare Research & Data Analytics team at Clarivate, the top three best-selling products for Pfizer, AbbVie, Merck/MSD and Bristol Myers Squibb contributed more than half their revenue in 2022, ranging from 53.3% of AbbVie’s $51.8 billion in revenue to a whopping 67.2% for Bristol Myers Squibb’s $44.7

Pharma 52

Pharma Biopharma Medicine Competition 52

Pharmaceutical Technology

NOVEMBER 23, 2022

Lifted by increased interest after the onset of the Covid-19 pandemic, the sector is expected to balloon to US$853 billion by 2030. The city is also home to two research hospitals, Hamilton Health Sciences and St Joseph’s Healthcare Hamilton. City Competitiveness Index. per square foot (/ft2) in Hamilton, versus C$9.06/ft2

Marketing 52

Marketing Manufacturing Transportation Government 52

Every Ancillary

MAY 14, 2021

According to one estimate from P&S Research , this market is expected to grow nearly 5x by 2030! Cons: Highly competitive with new options continually emerging. The Regenerative Medicine sector has exploded in popularity in recent years, with that trend expected to continue for the foreseeable future. Opportunities: Liquid Amnion.

Medical sales 52

Medical sales Medical Sales Insurance 52

European Pharmaceutical Review

MARCH 24, 2023

According to GlobalData, competition to develop a first-to-market drug for NASH is strong. In the European Union, NASH affects nearly 10 million people and is expected to increase by more than 40 percent by 2030. 89bio is one of several companies advancing treatments. It is becoming the leading cause for liver transplants.

Medical 83

Medical Side effects Safety Pharmaceutical 83

PM360

AUGUST 9, 2022

With these launches came more complex science, which pushed biopharma’s evolution to integrate more medical engagement alongside the existing commercial focus for healthcare providers and payers. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. Challenges of the New World Order.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Spotio

FEBRUARY 9, 2023

The OECD recently said that spending on healthcare across the globe is now 8.8% Furthermore, the organization predicts it will outpace the GDP by 2030. Increased competition Your sales team also faces more competition than ever before. The medical field is growing. This is great news for those in medtech sales!

Sales 52

Sales Medical Doctors Sales process 52

pharmaphorum

NOVEMBER 10, 2022

Expressing a desire that a shared passion for innovation and excellence within cancer care should be put at the centre of policies in order to establish resilience and competitiveness, Montserrat did note that sustainability was also important across the 27 EU member states. Horizon Europe and cancer care post-2020.

Electronics 80

Electronics Government Patients Pharma 80

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. Hoffmann-La Roche Ltd based in Basel, Switzerland.

Manufacturing 74

Manufacturing Pharmaceutical Healthcare Healthcare 74

pharmaphorum

JANUARY 4, 2023

The Proposal hopes to address the concerns with the current system and support the EC’s vision for the EU’s digital transformation by 2030. providing personalised healthcare consisting in assessing, maintaining, or restoring the state of health of individuals. Rights for individuals.

Pharmaceutical 88

Pharmaceutical Electronics Healthcare Healthcare 88

Pharmaceutical Technology

JANUARY 11, 2023

By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Digital health is the revolution in healthcare,” says Doug Ward, the general manager of MEDIC at Mohawk College in Hamilton, Canada. “It The global market size is estimated to be more than $95.3bn 1.

Healthcare 52

Healthcare Healthcare Medical Electronics 52

Pharmaceutical Technology

JUNE 15, 2023

More specifically in the US, Sandoz claims biosimilars have been hampered by interchangeability regulatory guidelines and a lack of alignment across stakeholder groups for educational materials causing confusion amongst patients and healthcare professionals. The latter also impacted Canada and Brazil.

Education 52

Education Patients Healthcare Healthcare 52

Clarivate

DECEMBER 14, 2023

Pharmaceutical benefit managers, M&A activity among integrated delivery networks, disruption by nontraditional healthcare entities, enrollment, and the 2024 presidential election are five areas to pay attention to moving into 2024. Clarivate experts explain why these topics are ones to watch in 2024.

Marketing 52

Marketing Healthcare Healthcare Insurance 52